Michael F. Price’s GSK GSK Stock Holding History

Michael F. Price’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,000	Closed	-$2.1M	–	147
2021 Q3	$2.1M	Buy	+44,000	New	+$2.21M	0.24%	76

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Michael F. Price's GSK Position: Q4 2021 in Review

Michael F. Price sold out of GSK (GSK) in Q4 2021, closing a stake of 44,000 shares — an estimated $2.1M sold.

Michael F. Price first reported a position in GSK in Q3 2021 and held it in 1 quarter. The position peaked at $2.1M in Q3 2021. 920 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Michael F. Price reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
Michael F. Price sold 44,000 GSK shares in Q4 2021, an estimated $2.1M.
Michael F. Price first reported a position in GSK in Q3 2021 and held it in 1 quarter.
Michael F. Price's GSK position peaked at $2.1M in Q3 2021.
920 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Michael F. Price's 13F filing for Q4 2021, filed 14 Feb 2022.